Carmine Therapeutics
Cambridge
About Carmine Therapeutics
Carmine Therapeutics develops a novel type of gene therapy that utilizes extracellular vesicles produced in the laboratory.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2022)
- Website: carminetherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/carmine-therapeutics-24916 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.